Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

Antibody deficiency or hypogammaglobulinemia can have primary or secondary etiologies.
Primary antibody deficiency (PAD) is the result of intrinsic genetic defects, whereas …

Hypogammaglobulinemia has been described after solid organ transplantation and has
been associated with increased risk of infections. The aim of the study was to evaluate the …

Immunoglobulin (Ig) replacement therapy dramatically changed the clinical course of
primary hypogammaglobulinemias, significantly reducing the incidence of infectious events …

Opinion statement In treating cytomegalovirus (CMV) infection, it is crucial to decide whether
one is treating pre-emptively or if one is treating established disease. Disease may be …

Intravenous immunoglobulin (IVIG) with high titers to West Nile virus was used as an
adjuvant therapy for a patient with West Nile virus encephalitis that did not respond to …

The immune response to cytomegalovirus (CMV) infection is highly complex, including
humoral, cellular, innate, and adaptive immune responses. Detection of CMV by the innate …

BACKGROUND: Information regarding Clostridium difficile–associated diarrhea (CDAD)
after solid-organ transplantation (SOT) is scarce, particularly after heart transplantation (HT) …

C. difficile is a significant pathogen in solid organ transplant recipients. Multiple risk factors
are found in this population that may result in more severe disease. A high index of …

Hypogammaglobulinemia and infection risk in solid organ tran... : Current Opinion in Organ
Transplantation Hypogammaglobulinemia and infection risk in solid organ transplant recipients …